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Introduction
Maintaining the pulpally involved deciduous teeth
in a healthy state until the time of normal
exfoliation remains to be one of the challenges
for pedodontics. Several materials have become
popular as pulpotomy medicaments (1). The first
time formaldehyde containing medicaments
were used was in 1874, Formocresol (FC) (a
mixture of equal parts of tricresol and formalin)
has been used as the most common capping
material for pulp fixation for many years (1,2).
Success rate of FC pulpotomy has been 70-97%
in the last decades. Concerns have been raised
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Abstract
Introduction: There are various studies looking at the effects of formocresol (FC) and
mineral trioxide aggregate (MTA) on pulpotomy of primary molars. This is a systematic review
of literature comparing the success rates of MTA and FC in pulpotomy of primary molars.
Materials and Methods: The study list was obtained using PubMed, EMBASE, Scopus,
Science Citation Index, Iran Medex, Google Scholar, the Cochrane Library, and also some hand
searches contains through dental journals approved by the Iranian Ministry of Health. Papers
which met the inclusion were accepted. The quality of studies for the meta-analysis was assessed
by a series of validity criteria according to Jadad's scale. Eight qualified studies met the criteria.
Terms of clinical outcomes and radiographic findings were evaluated in all studies to assess
clinical success and root resorption. Fixed model was applied to aggregate the data of
homogenous studies. A random effect model was carried out for measuring the effect size of
heterogeneous studies.
Results: The overall clinical and radiographic success rates based on the data suggested
that MTA was superior to FC (P=0.004) with the Odds Ratio=3.535 and 95% confidence interval
(1.494-8.369).
Conclusion: Primary molars pulpotomy with MTA have better clinical and radiographic
success rates than FC. (Iranian Endodontic Journal 2008;3:45-9)
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about the toxicity, potential carcinogenicity,
cytotoxicity, allergenicity, systemic disturbances,
and the possibility of affecting the permanent
successors (2-5). FC in pulpotomy has been
replaced with sulfate ferric, electro surgery,
hydroxyapatite, bone morphogenic protein, laser,
and mineral trioxide aggregate (MTA) (6-8).
MTA is a biocompatible material which has been
proposed as a potential medicaments for
pulpotomy in primary teeth (1,5,7-9). In many
studies, the qualities of the results are affected
by lack of adequate samples, poor design and
inappropriate case selection. This makes the
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Table 2. Inclusion and exclusion criteria
1- All selected teeth were human primary molars with
vital pulps which have exposed by caries or trauma
2- All selected teeth had at least 6 months follow up.
3- All selected teeth had no clinical or radiographic
sign or symptoms such as internal root resorption,
inter radicular or periapical bone destruction,
periodontium involvement, swelling or sinus tract.
4- All selected teeth were restorable with stainless
steel crowns or amalgam.
5- The outcome was evaluated by clinical symptoms
and radiographic evaluation.
6- All cases were regarded as a failure when one or
more of the following signs were present: internal root
resorption, furcation radiolucency, periapical bone
destruction, pain, swelling or sinus tract.
Exclusion criteria
1- Non randomized clinical trials
2- Different treatment methods
3- In vitro, retreat or animal studies, or histological
evaluation without clinical and radiographic
assessment.
4- No comparison between MTA and formocresol
5- The article could not be located.
All the studies were assessed separately and the
quality of studies used for meta-analysis was
evaluated by a series of validity criteria according
to Jadad's scale (11). Eight randomized clinical trial
studies were included. Two evaluators who were
blind to authors assessed the studies independently.
Over all clinical and radiographic success rates
were assessed as outcome variables. The criteria
for quality were based on the following:
1) Was the study randomized clinic trial?
2) Was the study described double-blind?
3) Was there a description of withdrawals and
dropouts?
The scores for the first 2 questions ranged from
0 to 2 and for last question 0 to 1. The well
designed studies with higher weight will exert
greater influence in the meta-analysis. Results
are summarized in Table 3.
Results
Studies with 1 year follow up: Heterogeneity
test suggested no significant difference in overall
success rate (P=0.55) than when a fixed model
studies unreliable and introduces limitation to the
results. In an attempt to overcome the problem
of reduced statistical power, meta-analysis
combines the results of several studies that
address a set of related research hypotheses
and can allow more accurate data analysis
(10,11). The purpose of this article is applying
meta-analysis to compare the clinical and
radiographic success of MTA with FC as
medicaments in primary molars pulpotomy.
Materials and Methods
The study list was obtained by using PubMed
(1960-March 2008), EMBASE (1984-March
2008), Scopus (1996-March 2008), Science
Citation Index (SCI) (1995-March 2008), Iran
Medex (2004-March 2008), Google Scholar
(1996-March 2008), the Cochrane library (1999-
March 2008) and also hand searches through
dental journals approved by the Iranian Ministry
of Health. The key words used are provided in
Table 1. Only those papers which met the
inclusion criteria's were accepted. The search
ended in March 2008 and languages of the search
were limited to English and Persian. Inclusion
and exclusion criteria's have been listed in Table
2. Each study was seperately assessed by at
least two reviewers.
Inclusion criteria
Table 1. The key words used in the Medline search
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(Peto odds ratio) was used to aggregate data of
these three studies. Findings of this meta-
analysis showed that the success rate of MTA
was comparable with FC and there was no
significant difference between them (P=0.52)
(Figure 1). Also Begg's rank correlation showed
no publication bias (P=0.6) (Figure 2).
All studies: The results of the heterogeneity test
suggests that the MTA and FC groups were
significantly heterogeneous (P=0.02) next a
random effect model was used to aggregate data
of all included studies. Meta-analysis showed
that success rate of MTA is superior to FC
(P=0.004; CI: 1.494-8.369) (Figure 3). Begg's
rank correlation showed no publication bias
(P=0.14) (Figure 4).
In comparison of two upper groups of study, it
seems that time of follow up may influence the
effect size of studies; therefore a meta regression
analysis carried out to determine the effect of time.
Results of this regression showed that the follow
up intervals have no effect on the overall success
rates. (P=0.96 CI: -1.56 to 1.50) (Figure 5).
Discussion
In this review the clinical and radiographic
success rates of MTA were superior to FC.
MTA is a biocompatible material which provides
a biological seal and has been proposed as a
potential medicaments for pulpotomy in primary
teeth (1,2,9,12,13).
As there are limited number of studies available
and sometimes different or even controversial
results, meta-analysis is a good option to provide
consistent results and suggestions for clinical
practice. This meta-analysis evaluated the
prognosis of pulpotomy in primary molar with FC
versus MTA clinically and radiographically. We
have listed our findings in Table 3. All 8 studies
demonstrated that the case was regarded as
failure in presence of one or more of the following
signs: pain, swelling, furcation radiolucency,
periapical bone destruction and sinus tract.
Periodontal ligament space widening was not
Figure 1. Meta-analysis (odds ratio) of studies with 12 month follow up
Table 3. Data summary of included studies
Figure 2. Funnel Plot of Standard Error by Peto odds
ratio
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identified as a failure in almost all studies except
Jabbarifar (14) and Agamy (15). We did not
include PDL widening in radiographs as a failure.
Internal root resorption was identified as a failure
in almost all included studies except Holan
et al. (4). They argued that internal root
resorption should be regarded as failure only if
the process reached the root's outer surface, and
induced an inflammatory process in the
periodontal ligament and surrounding bone. In
this meta-analysis, internal root resorption was
seen as a failure result. MTA used in Jabbarifar's
study (14) was ProRoot MTA, Kosari et al. (16)
used Iranian MTA, and Agamy (15) compared
relative success of gray MTA and white MTA.
In this meta-analysis, there was no difference
between gray and white MTA.
Pulp canal obliteration (PCO) was the most
common radiographic finding in both groups.
PCO is the result of odontoblastic activity and
suggests that the tooth is retaining some degree
of vitality (17-19).
Following points affect the final degree of
reliability of meta-analysis:
A) The randomization method will exclude
subjective interference in case selection and
distribution. Except Edilman et al. (17),
Jabbarifar et al. (14), Holan et al. (4), Aienechi
et al. (20), and Farsi et al. (21) studies failed to
describe their ways of randomization clearly.
B) Allocation concealing, (ie, patient and outcome
assessor were blinded to the treatments
allocation), will guarantee an accurate
assessment. This was reported only in the studies
of Edileman et al. (17), Holan et al. (4), Agamy
et al. (15), and Jabbarifar et al. (14).
C) A small sample size will lead to decreased
reliability, whereas a large one will cause the
difficulties of trial control and obtaining long term
data, as well as increased cost and time.
D) Deciduous teeth have a shorter life span, so
studies with longer follow up will be at the risk
of losing case information. Longer observation
periods may lead to observed lower success
rates than shorter times. In the 8 studies there
were different observation periods, a minimum
of 6 months was required as part of the inclusion
criteria in this meta-analysis.
Figure 3. Meta-analysis (odds ratio) of all studies
Figure 4. Funnel Plot of Standrad Error by Log Peto
odds ratio (all studies)
Figure 5. Scatter plot of meta regression of follow
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In Pengle et al. (22) meta-analysis study, 6
studies were included for meta-analysis and their
results concurred with ours. The pool of data
was taken from different sources in Pengle's
study (including the Iranian Ministry of Health
approved dental journals). Moreover this
information was collected two years after
completing Pengle's study.
Conclusion
Based on the present evidence, MTA can be
used as a suitable replacement for FC in primary
teeth especially in young children with multiple
teeth requiring pulpotomy treatment.
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